BillionToOne is a precision diagnostics company that quantifies biology to create powerful molecular diagnostics. We work to improve disease detection by counting molecules with our proprietary molecular counting platform. We place patients at the forefront of everything we do. We are currently applying our proprietary technology to non-invasive prenatal screening and liquid biopsy. We strive to remove the fear of the unknown by providing molecular diagnostics that are accurate, fast, and accessible. We challenge the status quo that makes healthcare expensive, opaque, and out of reach for the majority. Ultimately, all patients can access and are empowered by quantified genetic information about what is going on in their bodies and disease is detected early. Core values unite our brilliant and diverse team at BillionToOne. The consistent demonstration of these values helps bring our vision steps closer to reality. Our Code of Conduct provides the principles that help us select the right path when faced with decisions and promote a culture in which the right things are consistently done in the right way.
UNITY Complete is the only test of its kind. It can determine if there may be changes to the baby’s genes (recessive conditions) and chromosomes (aneuploidies). These insights are possible with just one blood draw from mom.
Most expecting families can learn early there is a low chance their baby will be born with certain medical conditions. This information can provide peace of mind. For pregnancies at higher risk, having this information early helps you and your doctor make informed decisions. Early intervention can make a difference. Therapies are most effective when initiated before symptoms begin, making prenatal diagnosis critical. LEARN MORE
